
Non-Invasive Prenatal Testing (NIPT)
The Pregnancy Experts offer VeriSeq NIPT Solution v2 by Illumina as their chosen NIPT provider.
This is the most advanced non-invasive pregnancy screening available for parents who would like to determine if they have a low or high probability of their baby having a genetic condition. The conditions tested for are Down syndrome (trisomy 21), Edward syndrome (trisomy 18) and Patau's syndrome (trisomy 13). Additionally testing for fetal sex chromosome problems and fetal sex can be performed at the parents request.
The test can be taken from as early as 10 weeks or any stage later in the pregnancy.
Some parents choose to have this test performed prior to their NHS nuchal translucency scan or even later in the pregnancy, after the NHS nuchal translucency or anomaly scan has been performed.
The test involves taking a blood sample from the mother's arm. This sample can be tested for the presence of cell free DNA (cfDNA) which represents a sample of DNA from the placenta and developing baby. This cfDNA is then analysed and the results determine if there is a low probability or high probability of your developing baby being affected by the screened conditions.
Given the test is a simple blood test on the mother, there is no increased risk of miscarriage from having the test performed.
The test can be performed in singleton pregnancies (one baby), twin pregnancies, singleton donor and surrogate pregnancies.
You can choose to find out the sex of your baby from this test - this is an optional test performed at no extra charge. Please call to discuss fetal sexing in twins with one of our clinicians if you are having a twin pregnancy.




